{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:40:37Z","timestamp":1775122837600,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":321,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jtauto.2020.100071","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T11:59:25Z","timestamp":1605873565000},"page":"100071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-1179","authenticated-orcid":false,"given":"Roman","family":"Saternus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Schwingel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia S.L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Reichrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100071_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00105-009-1909-8","article-title":"Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy","volume":"61","author":"Tr\u00e9mezaygues","year":"2010","journal-title":"Hautarzt"},{"key":"10.1016\/j.jtauto.2020.100071_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","article-title":"Pathophysiology of pyoderma gangrenosum (PG): an updated review","volume":"73","author":"Braswell","year":"2015","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100071_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2230.2011.04137.x","article-title":"Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum","volume":"36","author":"Nesterovitch","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s15012-019-2886-y","article-title":"Autoinflammatorische syndrome in der Dermatologie","volume":"35","author":"Engels","year":"2019","journal-title":"Hautnah Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100071_bib6","first-page":"375","article-title":"Report of a case of familial mediterranean fever with special emphasis on histopathologic characteristics","volume":"3","author":"M\u00fcller","year":"2016","journal-title":"Global Dermatology"},{"issue":"7381","key":"10.1016\/j.jtauto.2020.100071_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jtauto.2020.100071_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/ibd\/izy061","article-title":"Novel NOD2 mutation in early-onset inflammatory bowel phenotype","volume":"18","author":"Girardelli","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.jtauto.2020.100071_bib9","first-page":"762","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"J.A.M.A. Dermatol."},{"key":"10.1016\/j.jtauto.2020.100071_bib10","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.4049\/jimmunol.176.10.5898","article-title":"CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST","volume":"176","author":"Yang","year":"2006","journal-title":"J.\u00a0Immunol."},{"issue":"24","key":"10.1016\/j.jtauto.2020.100071_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/17.24.7320","article-title":"A\u00a0cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion","volume":"17","author":"Li","year":"1998","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100071_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jtauto.2020.100071_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semarthrit.2015.02.012","article-title":"Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA-syndrome)","volume":"25","author":"Lindwall","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib14","first-page":"32","article-title":"A\u00a0dermatologic perspective on autoinflammatory diseases","volume":"36","author":"Marzano","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"23","key":"10.1016\/j.jtauto.2020.100071_bib15","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100071_bib16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2015.04.016","article-title":"Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)\u2013associated inflammatory diseases","volume":"136","author":"Holzinger","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.jtauto.2020.100071_bib17","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1152\/ajpregu.00504.2006","article-title":"Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes","volume":"1","author":"Simon","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"19","key":"10.1016\/j.jtauto.2020.100071_bib18","doi-asserted-by":"crossref","first-page":"16474","DOI":"10.1074\/jbc.C300095200","article-title":"Gamma-secretase activity is associated with a conformational change of nicastrin","volume":"278","author":"Shirotani","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100071_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjd.18003","article-title":"PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens","volume":"181","author":"Gottlieb","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100071_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A\u00a0new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jtauto.2020.100071_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00105-007-1331-z","article-title":"Pyogenic arthritis, pyoderma gangrenosum and acne syndrome (PAPA syndrome)","volume":"58","author":"Renn","year":"2007","journal-title":"Hautarzt"},{"issue":"2","key":"10.1016\/j.jtauto.2020.100071_bib22","first-page":"209","article-title":"Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment","volume":"149","author":"Geusau","year":"2013","journal-title":"J.A.M.A. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib23","first-page":"452","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab","volume":"30","author":"Lee","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2020.100071_bib24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jtauto.2020.100071_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2004.08.001","article-title":"Abnormal production of tumor necrosis factor (TNF) -- alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome","volume":"145","author":"Cortis","year":"2014","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jtauto.2020.100071_bib26","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","article-title":"Peculiarities of PAPA syndrome","volume":"45","author":"Tallon","year":"2006","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.jtauto.2020.100071_bib27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","volume":"71","author":"Toplak","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100071_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006147","article-title":"Pyrin modulates the intracellular distribution of PSTPIP1","volume":"7","author":"Waite","year":"2009","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.jtauto.2020.100071_bib29","first-page":"956","article-title":"A\u00a0novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome","volume":"32","author":"Fathalla","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2008.11.017","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene","volume":"61","author":"Hong","year":"2009","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100071_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr. Dermatol."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100071_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","article-title":"Clinical efficacy of etanercept for treatment of PAPA syndrome","volume":"16","author":"Tofteland","year":"2010","journal-title":"J.\u00a0Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr. Dermatol."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100071_bib35","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh479","article-title":"Anakinra for flares of pyogenic arthritis in PAPA syndrome","volume":"44","author":"Dierselhuis","year":"2005","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jtauto.2020.100071_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) \u2013 a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2020.100071_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-3476(78)80501-0","article-title":"Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris","volume":"93","author":"Bj\u00f6rkst\u00e9n","year":"1978","journal-title":"J.\u00a0Pediatr."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib39","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","article-title":"PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition","volume":"72","author":"Saraceno","year":"2015","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/bjd.14383","article-title":"PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome","volume":"175","author":"Calder\u00f3n-Castrat","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"27","key":"10.1016\/j.jtauto.2020.100071_bib41","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","article-title":"Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases","volume":"93","author":"Marzano","year":"2014","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.jtauto.2020.100071_bib42","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjd.13668","article-title":"First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome","volume":"173","author":"Duchatelet","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100071_bib43","first-page":"e213","article-title":"A, Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome","volume":"45","author":"Saito","year":"2018","journal-title":"J.\u00a0Dermatol."},{"issue":"11","key":"10.1016\/j.jtauto.2020.100071_bib44","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/jdv.12765","article-title":"Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone","volume":"29","author":"Staub","year":"2015","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venerol."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib45","first-page":"17","article-title":"Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome","volume":"18","author":"Lamiaux","year":"2017","journal-title":"J.A.A.D. Case Rep"},{"issue":"5 Suppl 1","key":"10.1016\/j.jtauto.2020.100071_bib46","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jaad.2015.07.040","article-title":"Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients","volume":"73","author":"Join-Lambert","year":"2015","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jdv.12631","article-title":"Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?","volume":"30","author":"Garzorz","year":"2016","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100071_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.abd.2019.02.012","article-title":"PsAPASH: a rare and recent autoinflammatory syndrome associated with hidradenitis suppurativa","volume":"95","author":"Gadelha","year":"2020","journal-title":"An. Bras. Dermatol."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100071_bib49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","article-title":"Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor \u03b1 therapy","volume":"18","author":"Bruzzese","year":"2012","journal-title":"J.\u00a0Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100071_bib50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000443648","article-title":"PASS syndrome: an IL-1-driven autoinflammatory disease","volume":"232","author":"Leuenberger","year":"2016","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jtauto.2020.100071_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/ced.12585","article-title":"Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene","volume":"40","author":"Zeeli","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100071_bib52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00105-018-4312-5","article-title":"PAPA-Syndrom mit Morbus Crohn und prim\u00e4r sklerosierender Cholangitis\/Autoimmunhepatitis-Overlap-Syndrom","volume":"70","author":"Sch\u00e4ffler","year":"2019","journal-title":"Hautarzt"},{"key":"10.1016\/j.jtauto.2020.100071_bib53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.12659\/AJCR.898027","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PA-PASH) syndrome: an atypical presentation of a rare syndrome","volume":"17","author":"Ursani","year":"2016","journal-title":"Am. J. Case Rep."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100071_bib54","first-page":"70","article-title":"Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis","volume":"3","author":"Niv","year":"2017","journal-title":"J.A.A.D. Case Rep."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100071_bib55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00384-014-2110-9","article-title":"Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis","volume":"30","author":"Murphy","year":"2015","journal-title":"Int. J. Colorectal Dis."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100071_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/BOR.0000000000000314","article-title":"Alarming consequences \u2013 autoinflammatory disease spectrum due to mutations in proline-serinethreonine phosphatase-interacting protein 1","volume":"28","author":"Holzinger","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100071_bib57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138920210793175921","article-title":"Clinical, molecular, and genetic characteristics of PAPA syndrome: a review","volume":"11","author":"Smith","year":"2010","journal-title":"Curr. Genom."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100071_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909020300381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909020300381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:33:59Z","timestamp":1762904039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909020300381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":58,"alternative-id":["S2589909020300381"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2020.100071","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2020.100071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100071"}}